Clinical Trials Market to Reach USD 112.9 Billion by 2035, Driven by Rising Chronic Diseases and Advanced Therapies

The global clinical trials market is undergoing significant transformation as pharmaceutical companies, biotechnology firms, medical device manufacturers, and research organizations accelerate the development of innovative therapies. The global clinical trials industry was valued at US$ 64.7 Bn in 2024 and is projected to expand at a CAGR of 5.2% from 2025 to 2035, surpassing US$ 112.9 Bn by 2035.

Clinical trials are essential for establishing the safety, efficacy, dosage, and long-term performance of drugs, biologics, vaccines, medical devices, and advanced therapies. The market encompasses protocol design, patient recruitment and site identification, laboratory and bioanalytical testing, clinical data management, trial supply and logistics, and patient engagement services.

Increasing R&D expenditure, growing prevalence of chronic diseases, expansion of personalized medicine, and rising adoption of digital clinical trial technologies are reshaping the industry. Sponsors are increasingly outsourcing complex trial activities to contract research organizations (CROs) to reduce costs, improve operational efficiency, access specialized expertise, and accelerate time to market.

Access an overview of significant conclusions from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=78053

Key Drivers of Market Growth

Rising Prevalence of Chronic Diseases

The growing global burden of cancer, diabetes, cardiovascular disorders, respiratory diseases, and neurological conditions is generating sustained demand for new treatments. Increasing life expectancy and aging populations are also contributing to the complexity of chronic disease management.

Clinical trials remain indispensable for evaluating novel therapies and treatment combinations. According to the World Health Organization, more than 14% of adults aged 18 years and older were living with diabetes in 2022, compared with approximately 7% in 1990. Meanwhile, the Global Cancer Observatory recorded more than 19.9 million new cancer cases globally in 2022.

Increased Focus on Novel Therapies

The development of gene therapies, cell therapies, biologics, immunotherapies, RNA-based medicines, and personalized treatments is creating new opportunities for clinical research organizations. These therapies frequently require specialized protocols, advanced biomarkers, sophisticated endpoints, and innovative study designs.

The success of mRNA-based COVID-19 vaccines has also accelerated interest in mRNA technologies, while cell and gene therapies continue to expand clinical development pipelines.

Key Players and Industry Leaders

Competition in the clinical trials market is increasingly centered on technology capabilities, geographic reach, patient access, specialized therapeutic expertise, and integrated service offerings.

Prominent companies operating in the market include IQVIA Inc., Labcorp, Syneos Health, Charles River Laboratories, Thermo Fisher Scientific Inc., Parexel International (MA) Corporation, WuXi AppTec, Pfizer Inc., ICON plc, ACM Global Laboratories, Medpace, Invivoscribe, Inc., Velocity Clinical Research, PSI, BioAgile Therapeutics Private Limited, and Verily.

Leading providers are developing integrated platforms combining electronic data capture (EDC), clinical trial management systems (CTMS), randomization and trial supply management (RTSM), safety systems, and electronic clinical outcome assessments (eCOA). Strategic acquisitions and partnerships with hospital networks, home healthcare providers, laboratories, and technology companies are further expanding capabilities.

Explore our report to gain an in-depth view of the key findings - https://www.transparencymarketresearch.com/clinical-trials-market.html

Key Trends for the Future

One of the most important trends is the adoption of decentralized and hybrid clinical trials. These models integrate telemedicine, home healthcare, digital health technologies, and community-based research locations, allowing participants to take part without frequent visits to traditional research centers.

Another major trend is the increasing use of master protocols, including basket, umbrella, and platform trials. These approaches enable researchers to evaluate multiple interventions or patient groups under a common framework, potentially reducing study timelines and operational duplication.

Patient-centricity is also becoming a strategic priority. Sponsors are simplifying protocols, introducing digital consent, improving participant communication, and providing concierge-style services to reduce participant burden and improve retention.

New Opportunities and Challenges

The expansion of clinical research into emerging markets provides significant opportunities for sponsors and CROs. Asia Pacific, Latin America, and other developing regions offer access to diverse patient populations, expanding healthcare infrastructure, and growing research capabilities.

AI-enabled patient matching, site selection, recruitment forecasting, and trial feasibility assessment represent additional growth opportunities. External control arms, synthetic data approaches, direct-from-device data capture, and electronic source documentation can potentially accelerate data generation and reduce operational inefficiencies.

However, the industry continues to face challenges related to patient recruitment, regulatory complexity, data privacy, cybersecurity, protocol design, rising trial costs, and fragmented healthcare data. Ensuring interoperability between electronic health records, clinical trial platforms, laboratories, and wearable devices remains an important priority.

Future Outlook

The clinical trials market is expected to maintain steady growth through 2035 as healthcare companies increase investment in innovative treatments and precision medicine. Greater use of decentralized research, AI-enabled workflows, patient-centric recruitment, and real-world evidence is expected to improve trial efficiency.

Phase III studies are likely to continue representing a major component of market activity because they require large patient populations and generate extensive evidence needed for regulatory approval and commercialization. At the same time, increasing development of cell and gene therapies may create demand for specialized trial services and advanced laboratory capabilities.

North America is expected to remain a leading regional market due to its established healthcare infrastructure, strong pharmaceutical and biotechnology ecosystem, significant R&D spending, and supportive regulatory environment.

Buy this Premium Research Report to access critical market intelligence - https://www.transparencymarketresearch.com/checkout.php?rep_id=78053<ype=S

Market Segmentation

The clinical trials market can be segmented by service type, therapeutic area, trial phase, study design, type of intervention, sponsor type, and region.

By Service Type:

• Protocol Designing, Patient Recruitment & Site Identification, Laboratory Services, Bioanalytical Testing Services, Clinical Trial Supply & Logistics Services, Clinical Trial Data Management Services, Patient Engagement Services, Other Services

By Therapeutic Area:

• Cardiovascular Disorders, Neurological Disorders, Oncological Disorders, Metabolic Disorders, Respiratory Disorders, Autoimmune Disorders, Pain Management, Infectious Diseases, Others

By Trial Phase:

• Phase 0, Phase I, Phase II, Phase III, Phase IV

By Study Design:

• Interventional, Observational, Expanded Access

By Type of Intervention:

• Vaccines, Monoclonal Antibodies, Cell & Gene Therapy, Small Molecules, Medical Devices and Others

By Sponsor Type:

• Pharmaceutical and Biotechnology Companies, Government Organizations, Non-Government Organizations, Others

By Region:

• North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Important FAQs

How big was the global clinical trials market in 2024?

The global clinical trials market was valued at US$ 64.7 Bn in 2024.

How big will the clinical trials market be in 2035?

The global clinical trials market is projected to reach US$ 112.9 Bn by 2035.

What is driving the clinical trials market?

Key growth factors include the rising prevalence of chronic diseases, increasing R&D investment, development of novel therapies, expansion of personalized medicine, globalization of clinical research, and adoption of AI and digital technologies.

What will be the CAGR of the clinical trials market from 2025 to 2035?

The market is projected to expand at a CAGR of 5.2% between 2025 and 2035.

Who are the prominent players in the clinical trials market?

Major players include IQVIA Inc., Labcorp, Syneos Health, Charles River Laboratories, Thermo Fisher Scientific Inc., Parexel International (MA) Corporation, WuXi AppTec, Pfizer Inc., ICON plc, ACM Global Laboratories, Medpace, Invivoscribe, Inc., Velocity Clinical Research, PSI, BioAgile Therapeutics Private Limited, and Verily.

More Related Reports -

Horseradish Peroxidase Market: https://www.transparencymarketresearch.com/horseradish-peroxidase-market.html

Ketoanalogue for Kidney Disease Market: https://www.transparencymarketresearch.com/ketoanalogue-for-kidney-disease-market.html

Membrane Filters Market: https://www.transparencymarketresearch.com/membrane-filters-market.html

Radiation Therapy Market: https://www.transparencymarketresearch.com/radiation-therapy-market.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analyzed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com

Sales Inquiries: sales@transparencymarketresearch.com